title: Poor definitions threaten drug trial safety in India.
abstract: India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.
authors.affiliation: Jindal Global Law School at OP Jindal Global University in Sonipat, Haryana, India.
authors.forename: Nupur
authors.initials: N
authors.lastname: Chowdhury
mesh_terms: D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000592:standards*; D033161:Government Regulation; D006801:Humans; D007194:India; D019300:Medical Errors; D020416:Outsourced Services; D012449:Safety